Australia approves new "anti-virus condom" to fight against HIV
Release date: 2014-07-24 According to the British "Daily Telegraph" reported on July 22, Australia has issued a production license for newly developed anti-virus condoms. The drug condom is said to fight viruses including AIDS and sexually transmitted diseases and will be available on the market within a few months. It is reported that the condom was developed by Australian biotechnology company Starpharma and contains a nanocomposite called VivaGel, which kills 99.9% of HIV and sexually transmitted diseases such as herpes. However, VivaGel's inventor, Dr. Jackie Fairley, CEO of Starpharma, also stressed that the condom is not 100% effective in preventing pregnancy and preventing the spread of sexually transmitted diseases. Recently, Starpharma has reached a cooperation agreement with Australian condom manufacturer Ansell, which is responsible for its production. In addition, the US Food and Drug Administration (FDA) is reviewing the condom to determine if it can be sold in the US market. It is estimated that if this condom is sold globally, it will generate an annual market value of more than A$1 billion (approximately RMB 5.848 billion). Source: International Online Head Immobilizer,Head Blocks,Emergency Head Immobilizer Supplier Head Immobilizer,Head Blocks,Emergency Head Immobilizer,Child Head Holder,Assembled Head Immobilizer Luck Medical Consumables Co.,LIMITED , https://www.luckmedical.com